Stocks of Note for Feb-3 Morning
These stocks are making interesting moves on high volume.
Active Stocks Moving Up Today
Clene Inc. (CLNN) < (CLNN) is currently trading at $7.90 + 1.36 (20.80%). Clene Inc. (CLNN) < is -11.32% for the past 30 days, -12.32% year-to-date, and -24.62% over the last 12 months.
(No Data Available)
Usio Inc. (USIO) < (USIO) is currently trading at $5.39 + 0.65 (13.71%). Usio Inc. (USIO) < is +120.99% for the past 30 days, +101.87% year-to-date, and +247.08% over the last 12 months.
Payment Data Systems Inc is a United States based company engaged in providing integrated payment solutions. It offers range of customised services to merchants, billers, banks, service bureaus and card issuers.
Cancer Genetics Inc. (CGIX) < (CGIX) is currently trading at $4.15 + 0.5899 (16.57%). Cancer Genetics Inc. (CGIX) < is +52.70% for the past 30 days, +49.82% year-to-date, and +0.47% over the last 12 months.
Cancer Genetics Inc is an early-stage diagnostics company which develops, commercializes and provides molecular- and biomarker-based tests and services that enable physicians to personalize the clinical management of each individual patient.
Amplify Energy Corp. (AMPY) < (AMPY) is currently trading at $2.28 + 0.25 (12.32%). Amplify Energy Corp. (AMPY) < is +70.98% for the past 30 days, +74.05% year-to-date, and -56.84% over the last 12 months.
Midstates Petroleum Co Inc is in the business of oil and natural gas exploration and production. The company focuses on the application of drilling and completion techniques in oil and liquid rich basins in the United States.
Selecta Biosciences Inc. (SELB) < (SELB) is currently trading at $5.52 + 1.09 (24.69%). Selecta Biosciences Inc. (SELB) < is +74.59% for the past 30 days, +82.30% year-to-date, and +47.35% over the last 12 months.
Selecta Biosciences Inc is a clinical-stage biopharmaceutical company using its proprietary synthetic vaccine particle technology to discover and develop targeted therapies designed to modulate the immune system to treat rare and serious diseases.
MannKind Corporation (MNKD) < (MNKD) is currently trading at $4.34 + 0.495 (12.89%). MannKind Corporation (MNKD) < is +37.70% for the past 30 days, +38.50% year-to-date, and +187.33% over the last 12 months.
MannKind Corp is engaged in the discovery, development, and commercialization of therapeutic products for diseases such as diabetes and cancer. Its products and technologies include Afrezza, Dry powder formulation, Inhalation profiling, and others.
Evofem Biosciences Inc. (EVFM) < (EVFM) is currently trading at $3.43 + 0.41 (13.58%). Evofem Biosciences Inc. (EVFM) < is +36.93% for the past 30 days, +42.32% year-to-date, and -33.33% over the last 12 months.
Evofem Biosciences Inc provides woman-controlled protection from sexually transmitted infections. It addresses women\’s unmet medical needs through the discovery, development and commercialization of healthcare products.
Organigram Holdings Inc. (OGI) < (OGI) is currently trading at $2.22 + 0.27 (13.85%). Organigram Holdings Inc. (OGI) < is +69.04% for the past 30 days, +66.92% year-to-date, and -11.14% over the last 12 months.
Organigram Inc. is a Canadian licensed producer of cannabis products. Organigram focuses on producing exceptional, indoor-grown cannabis for patients and adult recreational consumers, as well as developing global business partnerships.
Zynerba Pharmaceuticals Inc. (ZYNE) < (ZYNE) is currently trading at $4.89 + 1.33 (37.25%). Zynerba Pharmaceuticals Inc. (ZYNE) < is +51.82% for the past 30 days, +48.06% year-to-date, and +0.20% over the last 12 months.
Zynerba Pharmaceuticals Inc together with its subsidiary is a pharmaceutical company which is focused on developing and commercializing proprietary next generation synthetic cannabinoid therapeutics formulated for transdermal delivery.
Tyme Technologies Inc. (TYME) < (TYME) is currently trading at $4.55 + 2.73 (149.99%). Tyme Technologies Inc. (TYME) < is +220.49% for the past 30 days, +272.94% year-to-date, and +179.29% over the last 12 months.
Tyme Technologies Inc is a clinical-stage pharmaceutical company focused on discovering and developing targeted cancer therapeutics for a broad range of oncology indications. The company is developing proprietary combination drug product.
Active Stocks Moving Down Today
Rezolute Inc. (RZLT) < (RZLT) is currently trading at $15.66 – 1.64 (9.48%). Rezolute Inc. (RZLT) < is +30.53% for the past 30 days, +30.61% year-to-date, and +125.18% over the last 12 months.
Rezolute Inc is a clinical stage biopharmaceutical company specializing in the development of innovative drug therapies to improve the lives of patients with metabolic and orphan diseases.
Rand Capital Corporation (RAND) < (RAND) is currently trading at $15.28 – 1.5498 (9.21%). Rand Capital Corporation (RAND) < is -13.63% for the past 30 days, -13.18% year-to-date, and -0.42% over the last 12 months.
Rand Capital Corp is an internally managed investment company that lends to and invests in small and medium-sized companies in connection with other investors. It invests in financial instruments such as equity instruments, debt instruments, among others.
MingZhu Logistics Holdings Limited (YGMZ) < (YGMZ) is currently trading at $11.80 – 1.79 (13.17%). MingZhu Logistics Holdings Limited (YGMZ) < is +17.42% for the past 30 days, +16.14% year-to-date, and -- over the last 12 months.
(No Data Available)
Iteris Inc. (ITI) < (ITI) is currently trading at $6.01 – 1.0949 (15.42%). Iteris Inc. (ITI) < is +6.90% for the past 30 days, +6.28% year-to-date, and +18.20% over the last 12 months.
Iteris Inc provides intelligent information solutions to the traffic management & global agribusiness market. The Company is engaged in the development and application of technologies and software-based information systems that reduce traffic congestion.
Voyager Therapeutics Inc. (VYGR) < (VYGR) is currently trading at $6.95 – 1.05 (13.12%). Voyager Therapeutics Inc. (VYGR) < is +2.88% for the past 30 days, -2.80% year-to-date, and -37.40% over the last 12 months.
Voyager Therapeutics Inc in collaboration with Genzyme, conducts research and development work to develop therapies for the treatment of central nervous system disorders. It targets diseases such as Parkinson\’s, Alzheimer\’s Huntington\’s.
Tenable Holdings Inc. (TENB) < (TENB) is currently trading at $48.05 – 4.74 (8.98%). Tenable Holdings Inc. (TENB) < is -7.19% for the past 30 days, -8.06% year-to-date, and +71.92% over the last 12 months.
(No Data Available)
Check Point Software Technologies Ltd. (CHKP) < (CHKP) is currently trading at $124.00 – 10.10 (7.53%). Check Point Software Technologies Ltd. (CHKP) < is -8.01% for the past 30 days, -6.70% year-to-date, and +7.64% over the last 12 months.
Check Point Software Technologies Ltd develops, markets and supports a wide range of products and services for IT security. The company offers its customers a portfolio of network security, endpoint security, data security and management solutions.
Hyliion Holdings Corp. Class A (HYLN) < (HYLN) is currently trading at $15.81 – 1.3538 (7.89%). Hyliion Holdings Corp. Class A (HYLN) < is -2.91% for the past 30 days, -4.09% year-to-date, and +59.52% over the last 12 months.
(No Data Available)
Moleculin Biotech Inc. (MBRX) < (MBRX) is currently trading at $4.77 – 1.62 (25.35%). Moleculin Biotech Inc. (MBRX) < is -0.05% for the past 30 days, -0.26% year-to-date, and -7.47% over the last 12 months.
Moleculin Biotech Inc is a clinical-stage pharmaceutical company. The company is engaged in the development of anti-cancer drug candidates. Its drug development technologies include liposomal Annamycin, WP1122 and WP1066.
Vaxart Inc. (VXRT) < (VXRT) is currently trading at $9.85 – 13.4801 (57.78%). Vaxart Inc. (VXRT) < is +112.78% for the past 30 days, +72.50% year-to-date, and +659.38% over the last 12 months.
Vaxart Inc, formerly known as Aviragen Therapeutics Inc is a bio-pharmaceutical company. It is engaged in developing direct-acting antivirals to treat infections that affect a number of patients.
